News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Sakditad Saowapa: Excited to share our abstract on Proton pump inhibitors in HCC published in JCO
Sakditad Saowapa/X
Jun 5, 2025, 10:57

Sakditad Saowapa: Excited to share our abstract on Proton pump inhibitors in HCC published in JCO

Sakditad Saowapa, Oncologist at UI Holden Comprehensive Cancer Center, shared a post on X:

“Excited to share our abstract published in JCO!

PPIs in HCC = higher risks even after PSM.

  • Mortality: HR 1.18
  • DVT: HR 1.73 | PE: HR 1.96
  • GIB: HR 4.43 | HE: HR 3.26
  • SBP: HR 3.33 | Acute liver failure: HR 3.20
  • Global dataset | 57k+ pts

Honored to be part of this amazing team!”

Proton pump inhibitors and clinical outcomes in hepatocellular carcinoma patients: A propensity score–matched analysis from a global federated dataset.

Authors: Natchaya Polpichai, Sakditad Saowapa, Shu-Yen Chan, Manasawee Tanariyakul, Chanakarn Kanitthamniyom, Andrea Ortiz Maldonado, Chanokporn Puchongmart, Nattanicha Chaisrimaneepan, Miriam Paz Sierra, Phuuwadith Wattanachayakul, Rawipan Uaratanawong, Pharit Siladech, and Lukman Aderoju Tijani.

You can read the full article on Journal of Clinical Oncology.

Sakditad Saowapa: Excited to share our abstract on Proton pump inhibitors in HCC published in JCO

More posts featuring Sakditad Saowapa.

Andrea Ortiz Maldonado cancer Chanakarn Kanitthamniyom Chanokporn Puchongmart fight against cancer Global fight against cancer HCC hepatocellular carcinoma JCO Lukman Aderoju Tijani Manasawee Tanariyakul Miriam Paz Sierra Natchaya Polpichai Nattanicha Chaisrimaneepan OncoDaily Oncology Pharit Siladech Phuuwadith Wattanachayakul PPIs Proton pump inhibitors Rawipan Uaratanawong Sakditad Saowapa Shu-Yen Chan UI Holden Comprehensive Cancer Center
Special Coverage
Opinion
Sep 4, 2025, 23:59
Roberto Borea: Selected Liquid Biopsy Abstracts for WCLC25
Insight
Sep 4, 2025, 20:03
Aruni Ghose: AI-Enhanced Medical Imaging for Cancer Diagnosis
Insight
Sep 4, 2025, 19:35
A Reminder That Education Is Essential to Patient Care - Elekta
Dialogues
Sep 4, 2025, 18:19
MASCC 2025 Presidential Training Fellowship Spotlight: Dr. Colleen Ann Cuthbert
Immune Oncology
Sep 4, 2025, 16:49
LIBRETTO-431 East Asia Subgroup Results of First-line Selpercatinib vs Chemotherapy + Pembrolizumab in RET Fusion–Positive NSCLC
OncoDaily Pulse
Sep 4, 2025, 16:17
Mariam Sargsyan: Meet the Experts of VIRO 2025
OncoDaily Pulse
Sep 4, 2025, 16:08
Elizabeth Wulff-Burchfield: Meet the Experts of VIRO 2025
Voices
Sep 4, 2025, 15:59
Markus Kosch: Finding Strength After Diagnosis - A Conversation with Claudia Poguntke
Voices
Sep 4, 2025, 15:59
Common Sense Oncology India Hub Webinar – Insights on the MATTERHORN Trial
Voices
Sep 4, 2025, 15:56
Servier and IDEAYA Biosciences Partner to Advance Darovasertib for Uveal Melanoma
Voices
Sep 4, 2025, 15:55
Bridging Divides, Building Futures at the 2025 World Cancer Leaders’ Summit - UICC
Insight
Sep 4, 2025, 15:51
Christine Maheu: Systematic Review of Fear of Cancer Recurrence Measures